All blogs

Why early pharmaceutical packaging design matters in drug development

Pharmaceutical drug development is a complex, highly regulated and costly process. From early research through to clinical trials and regulatory approval, it can take many years, and significant investment, before a treatment reaches patients. Throughout this journey, attention is often focused on formulation, testing and regulatory milestones, while packaging decisions are sometimes left until the later stages of development.

The role of fit, friction and void management in protective packaging

When it comes to protective packaging, there’s a common misconception that more material automatically equals better protection. In reality, overstuffed boxes and excessive cushioning often mask underlying problems, and can even contribute to in-transit damage. Shifts, collisions, and pressure points inside the package are frequently the hidden culprits behind product damage. Extra material alone can’t solve these issues.

The essential role of pharmaceutical packaging layers

In the pharmaceutical industry, packaging is far more than a container. It is a critical safeguard for patient safety, regulatory compliance and product integrity across the entire supply chain. From the moment a medicine is produced to its arrival at hospitals, pharmacies or patients’ homes, each layer of packaging plays a vital role in protecting sensitive products from damage, contamination and tampering, while ensuring they reach their destination in perfect condition.

How UV readable labels protect patients and brands in pharmaceutical packaging

The pharmaceutical industry is facing a growing and increasingly complex threat landscape. Counterfeit drugs, product diversion, and tampering are no longer isolated risks; they are global challenges that endanger patients, compromise quality and erode brand trust. As supply chains become more complex and international, the opportunities for fraudulent activity increase, making product security more critical than ever.